Navigation Links
Clinical trial to test safety of drug targeting leukemia cells
Date:9/3/2014

Researchers at the University of California, San Diego School of Medicine, in partnership with the California Institute for Regenerative Medicine (CIRM) and Celgene Corporation, a New Jersey-based biopharmaceutical company, have launched a phase 1 human clinical trial to assess the safety and efficacy of a novel monoclonal antibody for patients with chronic lymphocytic leukemia (CLL).

CLL is the most common form of blood cancer in adults, with more than 15,000 new cases diagnosed each year in the United States. The new antibody targets ROR1, a protein used by embryonic cells during early development that is also exploited by cancer cells to promote tumor growth and metastasis the spreading of cancer throughout the body that is responsible for 90 percent of all cancer-related deaths.

ROR1 is not expressed by normal adult cells, making it a specific marker of cancer cells in general and cancer stem cells in particular. Because ROR1 is a primary driver of tumor growth and metastasis, researchers believe it presents an excellent target for anti-cancer therapy.

Developed at UC San Diego Moores Cancer Center by Thomas Kipps, MD, PhD, who holds the Evelyn and Edwin Tasch Chair in Cancer Research, and colleagues, the antibody is called cirmtuzumab (also known as UC-961). In previous animal studies, Kipps' team reported that ROR1 is singularly expressed on CLL and also on a variety of different cancers, including cancers of the breast, pancreas, colon, lung and ovary. In mouse models of CLL, ROR1 acts as an accelerant when combined with another oncogene to produce a faster-growing, more aggressive cancer.

Cirmtuzumab is based on a humanized anti-ROR1 monoclonal antibody that, in mouse studies, reduced levels of ROR1, impairing the growth and survival of CLL cells and making them more vulnerable to other anti-cancer drugs. Cirmtuzumab was developed under the auspices of the CIRM HALT leukemia grant awarded to Dennis Carson, MD, pr
'/>"/>

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Catalent Supports Eli Lilly's Growing Global Clinical Trials Needs with New Investment in Automated Packaging Solutions
2. Sleepless Nights, Exhausting Days, Mental Fog – Relief for Insomnia With Clinical Psychologist Dr. Carol Francis
3. Transvenous lead extraction clinically successful in 98 percent of cases
4. Healthpointe is Now Offering Clinical Rotations for Chapman University Physical Therapy Students
5. Novant Health Recognized for Excellence in Clinical Care
6. FDAnews Accounces New Newsletter: Clinical Trial Magnifier Weekly Provides the Most Up-to-Date Clinical Trial Data
7. TGen receives approval for patient enrollment in brain cancer clinical trial
8. American Telemedicine Association Issues Clinical Guidelines for Telepathology
9. Critical Path Sourcing Strategies for Global Clinical Trials Presented by Catalent Experts at US Clinical Trials Supply Conference
10. New Clinical Trial: Using the Listeria Virus to Fight Mesothelioma
11. veEDIS Clinical Systems “Delivers,” as the 2014 Edition CEHRT Emergency Department EHR System is Implemented at Lawrence Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2014)... (PRWEB) September 21, 2014 “Cluster headaches ... so intense and difficult to resolve,” said Steve Young ... can't think of a pain that is more intense.” ... suffers from cluster headaches, or migraines, that medical research ... the serotonin system,” he added. , Serotonin (5-HT, 5-hydroxytryptamine) ...
(Date:9/21/2014)... (PRWEB) September 21, 2014 Recently, BambooIndustry.com, ... a special offer for its bamboo panels ( http://www.bambooindustry.com/products/bamboo-panel/ ... the market; all of them are available at discounted ... , The company’s discounted bamboo panels are ... made of quality materials. Each of them is finely ...
(Date:9/21/2014)... Aliso Viejo, California (PRWEB) September 21, 2014 ... Pro X plugins have announced a new transition ... , “Transpack Vol. 3 delivers high quality transitions that ... video project,” said Christina Austin, CEO of Pixel Film ... Vol. 3 is a definite game changer.” , Transpack ...
(Date:9/21/2014)... Faculty and staff at Garrison Forest School (GFS), an ... Md., kicked off the academic year by taking a big ... first independent school to receive the bands— which calculate activity ... as part of a pilot program with Charm City ... The Vivofit bands are just one tool in a new ...
(Date:9/21/2014)... 2014 C8 lawsuits move forward in ... the list of 20 possible C8 lawsuits selected ... six, reports Wright & Schulte LLC. Court records show ... 2500 C8 lawsuits filed that represent individuals who purportedly ... a result of being exposed to water contaminated by ...
Breaking Medicine News(10 mins):Health News:Homeostasis: Equinox Serotonin (5HT) Headache Stories ~ New on the Bryan William Brickner Blog 2Health News:Discounted Bamboo Panels For Sale At BambooIndustry.com 2Health News:Pixel Film Studios Released Transpack Vol. 3 Plugin Exclusively for Final Cut Pro X 2Health News:Garrison Forest School Leader in Independent School Wellness Programs 2Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 2Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 3Health News:C8 Lawsuit Claims Move Forward as Six Possible Cases for Bellwether Trials Selected in DuPont Water Contamination Lawsuits, Reports Wright & Schulte LLC 4
... ... by the U.S. Food and Drug Administration (FDA), Immunovative Therapies, Ltd. ... vaccine product for the treatment of advanced metastatic solid tumors will begin ... inside the body by combining the experimental AlloStimTM drug with the killing ...
... ... software for long-term care will present a technology and admissions educational session for THCA ... Atlanta, ... Web-based admissions for long-term care providers, announced today that it will present a session ...
... ... ,fight the bite, from America,s most unwanted species; the aggressive, disease-carrying, Asian Tiger mosquito ... Mega-Catch™ mosquito traps. , ... Auckland, NZ (PRWEB) August 14, 2009 -- The patent-pending, Mega-Catch™ 3000 combo lure ...
... ... 40% of women find holidays more stressful than they should be. A male,s ... is their biggest nightmare. Under 30s are the most stressed on holiday. , ... Cardiff, UK (PRWEB) August 14, 2009 ...
... , , , SACRAMENTO, ... contribution of up to $81.4 million to the Healthy Families Program today ... at risk of losing coverage due to the state,s fiscal crisis. The ... used to cover children ages 0-5 through June 2010. , , ...
... find types of hormones used raise or lower clot ... composition of a woman,s contraceptive pill influences her risk ... European researchers say. , Scientists have long known that ... progestogen, increase the likelihood of deep vein thrombosis of ...
Cached Medicine News:Health News:CryoStim™ Cancer Treatment to Begin FDA Clinical Trials September 1, 2009 2Health News:CryoStim™ Cancer Treatment to Begin FDA Clinical Trials September 1, 2009 3Health News:Patient Placement Systems Presents a Session at the THCA 2009 Annual Convention 2Health News:Patient Placement Systems Presents a Session at the THCA 2009 Annual Convention 3Health News:Mega-Catch™ 3000 Combination Lure Attracts Asian Tiger Mosquitoes (Aedes Albopictus) 2Health News:Mega-Catch™ 3000 Combination Lure Attracts Asian Tiger Mosquitoes (Aedes Albopictus) 3Health News:Spain Has The 'Stress' Factor, According to Confused.com 2Health News:Spain Has The 'Stress' Factor, According to Confused.com 3Health News:First 5 California Approves $81.4 Million Contribution to Help Restore Healthy Families Program's Viability 2Health News:Some Birth Control Pills Safer Than Others 2Health News:Some Birth Control Pills Safer Than Others 3
(Date:9/19/2014)... 2014 Kiromic, LLC, a Lubbock ... Hance , the former chancellor of Texas Tech University, to ... in July 2014, after raising $1.2 billion for the university. ... Hance , the most successful chancellor in the history of ... as an investor, but also as our new vice chairman ...
(Date:9/19/2014)... Research and Markets has announced the ... Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023" ... this report, the human microbiome market is segmented by application, ... is expected to be valued as $294 million in 2019 ... within the forecast period of 2019-2023. The market is driven ...
(Date:9/19/2014)... WOONSOCKET, R.I. , Sept. 19, 2014 Five MinuteClinic ... Memphis metropolitan area. Three clinics opened in ... earlier this month. A fourth clinic will be added in ... in Bartlett is expected to open October ... medical clinics in the United States . ...
Breaking Medicine Technology:Former Texas Tech Chancellor Named New Vice Chairman of the Board of Kiromic, LLC 2Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 2Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 3MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3
... June 16, 2011 The largest human dermal allograft available ... will be introduced at the AWR meeting here this week. ... is introducing FlexHD acellular hydrated dermal matrix 20 ... cm x 25 cm grafts. FlexHD ...
... our scope of services, Shenzhen Wuzhou Changlian International Trading ... with a city hospital in the Southeast of Africa soon, ... equipment. Wuzhou Changlian has offered specialty body-care products ... which puts a focus on meeting local people,s needs and ...
Cached Medicine Technology:Largest Acellular Dermal Allografts Available for Abdominal Wall Reconstruction Introduced at AWR 2011 2Shenzhen Wuzhou Changlian International Trading Co. Establishes Relationship with Hospital in Africa 2
... launch of the NCP-2, ACS proudly introduces ... given physicians more tools for assessing the ... and only complete ECP Treatment Report.,The ACS ... program that allows both physicians and therapists ...
... G3-Automatic simplifies the rescue process by eliminating the ... you have to do is attach the device ... defibrillation pads are attached to the patient, the ... rhythm using the patented RHYTHMx software, and if ...
... Stethoscope Model 4100WS features amplification and proprietary ... to reduce ambient noise by an average ... sounds. Three frequency modes are available for ... sounds: Bell (20-200 Hz), Diaphragm (100-500 Hz), ...
... is a portable, battery-powered bone growth stimulator used ... device is worn for 30 minutes each day ... fusion site. The device uses a unique technology, ... energy signal that is very potent in its ...
Medicine Products: